Not logged inReal-world persistence and compliance of denosumab versus alendronate among postmenopausal women with osteoporosis in Asia-Pacific
Lau, Tang Ching; Chang, Dong-Gune; Chen, Chung-Hwan; Huang, Shuang; Lau, Edith M. C.; Law, Sheung-Wai; Lee, Young-Kyun; Tolman, Cae; Canals, Laura; Yeo, See-Hwee; Yu, Jing; Ebeling, Peter R. .png)
Share.png)
SaveSotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summaryde Langen, Adrianus Johannes; Johnson, Melissa L.; Mazieres, Julien; Dingemans, Anne-Marie C.; Mountzios, Giannis; Pless, Miklos; Wolf, Juergen; Schuler, Martin; Lena, Herve; Skoulidis, Ferdinandos; Yoneshima, Yasuto; Kim, Sang-We; Linardou, Helena; Novello, Silvia; van der Wekken, Anthonie J.; Chen, Yuanbin; Peters, Solange; Felip, Enriqueta; Solomon, Benjamin J.; Ramalingam, Suresh S.; Dooms, Christophe; Lindsay, Colin R.; Ferreira, Carlos Gil; Blais, Normand; Obiozor, Cynthia C.; Wang, Yang; Mehta, Bhakti; Varrieur, Tracy; Ngarmchamnanrith, Gataree; Stollenwerk, Bjoern; Waterhouse, David; Paz-Ares, Luis Share Save Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk, first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimenPeters, Christina; Bruno, Angela; Rizzari, Carmelo; Brescianini, Alessandra; von Stackelberg, Arend; Linderkamp, Christin; Zeng, Yi; Zugmaier, Gerhard; Locatelli, Franco Share Save Share Save Sotorasib (Soto) plus panitumumab (Pmab) and FOLFIRI in previously treated KRASG12C-mutated metastatic colorectal cancer (mCRC): Safety and efficacy for CodeBreaK 101 phase Ib expansion cohortMasuishi, T.; Strickler, J. H.; Machiels, J-P.; Hong, D. S.; Greil, R.; Chan, E.; Hippenmeyer, J.; Saportas, Y.; Cardona, P.; Xia, C.; Kuboki, Y. Share Save GUIDE.MRD: A Consortium guiding multi-modal therapies against minimal residual disease (MRD) by liquid biopsy to assess implementation of circulating tumor DNA (ctDNA) in clinical practice to improve patient outcomesPantel, K.; Andersen, C. Lindbjerg; Schuuring, E.; Malats, N.; Heitzer, E.; Vat, L.; Kiernan, E.; Chin, E.; Barrett, C.; Kapp, R.; Thomas, M.; Gerling, M.; Reck, M.; Lohr, M.; Hofman, P.; Hiltermann, N.; Alix-Panabieres, C.; Smit, J.; Bolisetty, M.; Karasarides, M. Share Save Share Save Share Save Share Save Share Save Share Save Share Save Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCIVallejo-Vaz, Antonio J.; Bray, Sarah; Villa, Guillermo; Brandts, Julia; Kiru, Gaia; Murphy, Jennifer; Banach, Maciej; De Servi, Stefano; Gaita, Dan; Gouni-Berthold, Ioanna; Hovingh, G. Kees; Jozwiak, Jacek J.; Jukema, J. Wouter; Kiss, Robert Gabor; Kownator, Serge; Iversen, Helle K.; Maher, Vincent; Masana, Luis; Parkhomenko, Alexander; Peeters, Andre; Clifford, Piers; Raslova, Katarina; Siostrzonek, Peter; Romeo, Stefano; Tousoulis, Dimitrios; Vlachopoulos, Charalambos; Vrablik, Michal; Catapano, Alberico L.; Poulter, Neil R.; Ray, Kausik K. Share Save Share Save Share Save Share Save Relationships Between Kohne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal CancerSartore-Bianchi, Andrea; Garcia-Alfonso, Pilar; Geissler, Michael; Kohne, Claus-Henning; Peeters, Marc; Price, Timothy; Valladares-Ayerbes, Manuel; Zhang, Ying; Burdon, Peter; Taieb, Julien; Modest, Dominik P. Share Save Share Save Share Save Characterization and Outcomes in Patients Treated With Apremilast in Routine Clinical Practice in Spain: Results From the APPRECIATE StudyHerranz, P.; Trasobares, L.; Mateu, A.; Martinez, E.; Ruiz-Villaverde, R.; Baniandres, O.; Mataix Diaz, J.; Jimenez-Gomez, N.; Serra, M.; Ruiz Genao, D. P.; Rivera, N.; Tercedor-Sanchez, J.; Garcia, C.; Cordey, M.; Herrera-Acosta, E. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
